Picture of Cyxone AB logo

CYXO — Cyxone AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Cyxone Gets Intention To Grant From European Patent Office For Divisional Patent Of T20K

May 31 (Reuters) - Cyxone AB  CYXO.ST :
    * CYXONE RECEIVES INTENTION TO GRANT FROM THE EUROPEAN
PATENT
OFFICE FOR THE DIVISIONAL PATENT OF T20K
    * APPLICATION COVERS PROTECTION OF DRUG CANDIDATE T20K THAT
CYXONE
LICENSES FROM MEDICAL UNIVERSITY OF VIENNA AND UNIVERSITY OF
FREIBURG.
    * WHEN ISSUED, PATENT WILL BE VALID UNTIL 2032.

Source text for Eikon:  ID:nWkr4bCVMk 
Further company coverage:  CYXO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))

Recent news on Cyxone AB

See all news